Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Merck & Company (MRK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 159,815,648
  • Shares Outstanding, K 2,724,440
  • Annual Sales, $ 39,807 M
  • Annual Income, $ 3,920 M
  • 36-Month Beta 0.76
  • Price/Sales 4.07
  • Price/Cash Flow 10.12
  • Price/Book 4.17

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.96 +10.92%
on 01/03/18
63.78 -2.68%
on 01/16/18
+5.83 (+10.37%)
since 12/15/17
3-Month
53.63 +15.74%
on 11/20/17
64.52 -3.80%
on 10/23/17
-1.27 (-2.01%)
since 10/16/17
52-Week
53.63 +15.74%
on 11/20/17
66.80 -7.08%
on 03/01/17
-0.27 (-0.43%)
since 01/13/17

Most Recent Stories

More News
Dow Touches New Intraday High, Finishes Lower

Merck (MRK), UnitedHealth (UNH), and Coca-Cola (KO) helped lift the Dow Jones Industrial Average above 26,000 on Tuesday, marking the fastest climb between 1,000-point barriers in the index's 121-year...

KO : 46.53 (+0.82%)
IBM : 163.85 (+0.44%)
MRK : 62.07 (+5.81%)
GS : 258.46 (+0.56%)
UNH : 232.90 (+1.86%)
With Social Media Use Set to Grow in 2018, Buy Twitter (TWTR)

The likes of Merck (MRK) and UnitedHealth (UNH) have helped lift the Dow to new heights in 2018, while early gains from Amazon (AMZN) just might have signaled that the tech sector is on track for another...

TWTR : 24.66 (-2.95%)
MRK : 62.07 (+5.81%)
AMZN : 1,304.86 (-0.03%)
UNH : 232.90 (+1.86%)
AllianceBernstein, Cementos Pacasmayo, Freddie Mac and Merck Honored at MicroStrategy World(TM) 2018

MicroStrategy(R) Incorporated (Nasdaq: MSTR), a leading worldwide provider of enterprise analytics and mobility software, today presented MicroStrategy Customer Awards to AllianceBernstein...

MSTR : 138.31 (-1.03%)
MRK : 62.07 (+5.81%)
3 Biotech Stocks Start Healthy in '18: Will the Rally Last?

We take a look at some biotech stocks that have witnessed an increase in their share price this year so far and look well positioned for the rest of 2018.

AGEN : 3.79 (-2.07%)
MRK : 62.07 (+5.81%)
VRTX : 155.71 (-1.41%)
NVS : 86.73 (+0.09%)
ALKS : 56.57 (-3.65%)
GSK : 37.92 (+1.12%)
MerckInvents@ TEC Edmonton Accepting Applications

Recruitment is now open for MerckInvents@ TEC Edmonton, a new health technology accelerator and partnership between TEC Edmonton, Merck Canada Inc. and the University of Alberta. Set to open March 2018,...

MRK : 62.07 (+5.81%)
AstraZeneca's Lynparza Label Now Includes Breast Cancer

AstraZeneca (AZN) and Merck (MRK) announce approval of label expansion of ovarian cancer drug, Lynparza, to include HER2-/HR+ breast cancer with germline BRCA-mutation.

AZN : 34.99 (-1.85%)
MRK : 62.07 (+5.81%)
MYGN : 35.79 (-0.72%)
CLVS : 55.41 (-6.10%)
Global Inhalation Drug Delivery Devices Market, 2017-2021 Featuring AstraZeneca, Boehringer, Ingelheim, GSK, Merck & Co, Novartis, Sunovion, Teva, SkyePharma/Vectura

The "Inhalation Drug Delivery Devices Market" report has been added to ResearchAndMarkets.com's offering.

MRK : 62.07 (+5.81%)
NVS : 86.73 (+0.09%)
LYNPARZA(R) (olaparib) Approved by US FDA in Germline BRCA-Mutated Metastatic Breast Cancer

--LYNPARZA reduced the risk of disease progression or death by 42% compared to standard of care chemotherapy

AZN : 34.99 (-1.85%)
MRK : 62.07 (+5.81%)
MYGN : 35.79 (-0.72%)
U.S. FDA Approves LYNPARZA(R) (olaparib) in Germline BRCA-Mutated Metastatic Breast Cancer

--LYNPARZA Reduced Risk of Disease Progression or Death by 42 Percent Compared to Standard of Care Chemotherapy

MYGN : 35.79 (-0.72%)
MRK : 62.07 (+5.81%)
Look for Shares of Merck & Co to Potentially Pullback after Yesterday's 1.51% Rise

Merck & Co (NYSE:MRK) traded in a range yesterday that spanned from a low of $57.89 to a high of $58.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $57.61...

MRK : 62.07 (+5.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies...

See More

Key Turning Points

2nd Resistance Point 64.90
1st Resistance Point 63.48
Last Price 62.07
1st Support Level 60.95
2nd Support Level 59.84

See More

52-Week High 66.80
Last Price 62.07
Fibonacci 61.8% 61.77
Fibonacci 50% 60.22
Fibonacci 38.2% 58.66
52-Week Low 53.63

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.